Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic ovary syndrome

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Benrick, Anna ^a   Maliqueo, Manuel ^a   Miao, Sun ^a   Villanueva, Jesus A ^b,c   Feng, Yi ^d   Ohlsson, Claes ^a   Duleba, Antoni J ^c   Stener Victorin, Elisabet ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; CHOLESTEROL; ESTROGEN RELATED RECEPTOR ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESVERATROL; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BONE DENSITY; BONE LENGTH; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORTICAL BONE; ESTRUS CYCLE; EXERCISE; FEMALE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; HOMA INDEX; INSULIN RESISTANCE; INSULIN SENSITIVITY; MESENTERY; METABOLISM; NONHUMAN; OBESITY; ORGAN WEIGHT; OVARY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RAT; REPRODUCTION; RETROPERITONEUM; SKELETAL MUSCLE; SOLEUS MUSCLE; STEROIDOGENESIS; SUBCUTANEOUS FAT; TIBIA; TRABECULAR BONE; TREATMENT FAILURE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; UTERUS;

EID: 84877269519     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/964070     Document Type: Article

References (58)

1. Gilling-Smith C., Willis D. S., Beard R. W., Franks S., Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 1994 79 4 1158 1165 2-s2.0-0028029753 10.1210/jc.79.4.1158 (Pubitemid 24342265)
2. Gambineri A., Patton L., Vaccina A., Cacciari M., Morselli-Labate A. M., Cavazza C., Pagotto U., Pasquali R., Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2006 91 10 3970 3980 2-s2.0-33749579388 10.1210/jc.2005-2250 (Pubitemid 44536872)
3. Sverrisdóttir Y. B., Mogren T., Kataoka J., Janson P. O., Stener-Victorin E., Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? American Journal of Physiology 2008 294 3 E576 E581 2-s2.0-40449140552 10.1152/ajpendo.00725.2007 (Pubitemid 351355228)
4. Faulds G., Rydén M., Ek I., Wahrenberg H., Arner P., Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 5 2269 2273 2-s2.0-0038030705 10.1210/jc.2002-021573 (Pubitemid 36549907)
5. Mannerås-Holm L., Leonhardt H., Kullberg J., Jennische E., Odén A., Holm G., Hellström M., Lönn L., Olivecrona G., Stener-Victorin E., Lönn M., Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2011 96 2 E304 E311 2-s2.0-79951701058 10.1210/jc.2010-1290
6. Skov V., Glintborg D., Knudsen S., Jensen T., Kruse T. A., Tan Q., Brusgaard K., Beck-Nielsen H., Højlund K., Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 2007 56 9 2349 2355 2-s2.0-34548429745 10.2337/db07-0275 (Pubitemid 47358242)
7. Covington J. D., Ravussin E., Redman L. M., Reduced expression of SIRT1 and SIRT3 in the skeletal muscle of PCOS women. The Endocrine Society's 95th Annual Meeting and Expo (ENDO '12) June 2013 San Francisco, Calif, USA
8. Mannerås L., Cajander S., Holmäng A., Seleskovic Z., Lystig T., Lönn M., Stener-Victorin E., A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 2007 148 8 3781 3791 2-s2.0-34547138420 10.1210/en.2007-0168 (Pubitemid 47105840)
9. Mannerås L., Cajander S., Lönn M., Stener-Victorin E., Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS. American Journal of Physiology 2009 296 4 R1124 R1131 2-s2.0-65949110339 10.1152/ajpregu.90947.2008
10. Jedel E., Labrie F., Odén A., Holm G., Nilsson L., Janson P. O., Lind A. K., Ohlsson C., Stener-Victorin E., Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. American Journal of Physiology 2011 300 1 E37 E45 2-s2.0-78650764162 10.1152/ajpendo.00495.2010
11. Feng Y., Johansson J., Shao R., Manneras-Holm L., Billig H., Stener-Victorin E., Electrical and manual acupuncture stimulation affect oestrous cyclicity and neuroendocrine function in an 5alpha-dihydrotestosterone- induced rat polycystic ovary syndrome model. Experimental Physiology 2012 97 651 662
12. Jiang H., Zhang L., Kuo J., Kuo K., Gautam S. C., Groc L., Rodriguez A. I., Koubi D., Hunter T. J., Corcoran G. B., Seidman M. D., Levine R. A., Resveratrol-induced apoptotic death in human U251 glioma cells. Molecular Cancer Therapeutics 2005 4 554 561 (Pubitemid 40601836)
13. Szkudelska K., Szkudelski T., Resveratrol, obesity and diabetes. European Journal of Pharmacology 2010 635 1-3 1 8 2-s2.0-77952321187 10.1016/j.ejphar.2010.02.054
14. Ortega I., Villanueva J. A., Wong D. H., Cress A. B., Sokalska A., Stanley S. D., Duleba A. J., Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway. Endocrinology 2012 153 4019 4029
15. Wong D. H., Villanueva J. A., Cress A. B., Duleba A. J., Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells. Molecular Human Reproduction 2010 16 4 251 259 2-s2.0-77952763886 10.1093/molehr/gaq002
16. Borra M. T., Smith B. C., Denu J. M., Mechanism of human SIRT1 activation by resveratrol. Journal of Biological Chemistry 2005 280 17 17187 17195 2-s2.0-20444444649 10.1074/jbc.M501250200 (Pubitemid 41389185)
17. Sang M. S., Il J. C., Sang G. K., Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3 β inhibition downstream of poly(ADP-ribose) polymerase-LKB1 pathway. Molecular Pharmacology 2009 76 4 884 895 2-s2.0-70349324339 10.1124/mol.109.058479
18. Park S. J., Ahmad F., Philp A., Baar K., Williams T., Luo H., Ke H., Rehmann H., Taussig R., Brown A. L., Kim M. K., Beaven M. A., Burgin A. B., Manganiello V., Chung J. H., Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012 148 421 433
19. Fernandez-Marcos P. J., Auwerx J., Regulation of PGC-1 α a nodal regulator of mitochondrial biogenesis. American Journal of Clinical Nutrition 2011 93 4 884S 890S 2-s2.0-79953210362 10.3945/ajcn.110.001917
20. Cantó C., Auwerx J., PGC-1 α SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Current Opinion in Lipidology 2009 20 2 98 105 2-s2.0-64549127790 10.1097/MOL.0b013e328328d0a4
21. Hawley J. A., Lessard S. J., Exercise training-induced improvements in insulin action. Acta Physiologica 2008 192 1 127 135 2-s2.0-37249066135 10.1111/j.1748-1716.2007.01783.x (Pubitemid 350265363)
22. Hoeger K. M., Exercise therapy in polycystic ovary syndrome. Seminars in Reproductive Medicine 2008 26 1 93 100 2-s2.0-38149074723 10.1055/s-2007-992929
23. Das S., Lin H. S., Ho P. C., Ng K. Y., The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharmaceutical Research 2008 25 11 2593 2600 2-s2.0-53849145999 10.1007/s11095-008-9677-1
24. Marcondes F. K., Bianchi F. J., Tanno A. P., Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian Journal of Biology 2002 62 4 609 614 2-s2.0-0003255738
25. Björnheden T., Jakubowicz B., Levin M., Odén B., Edén S., Sjöström L., Lönn M., Computerized determination of adipocyte size. Obesity Research 2004 12 1 95 105 2-s2.0-17144444097 (Pubitemid 41137492)
26. Ortega I., Cress A. B., Wong D. H., Villanueva J. A., Sokalska A., Moeller B. C., Stanley S. D., Duleba A. J., Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells. Biology of Reproduction 2012 86 1 9
27. Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A., Prabhu V. V., Allard J. S., Lopez-Lluch G., Lewis K., Pistell P. J., Poosala S., Becker K. G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K. W., Spencer R. G., Lakatta E. G., Le Couteur D., Shaw R. J., Navas P., Puigserver P., Ingram D. K., De Cabo R., Sinclair D. A., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006 444 7117 337 342 2-s2.0-33751072349 10.1038/nature05354 (Pubitemid 44764104)
28. Rivera L., Morón R., Zarzuelo A., Galisteo M., Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochemical Pharmacology 2009 77 6 1053 1063 2-s2.0-60949087943 10.1016/j.bcp.2008.11.027
29. Palsamy P., Subramanian S., Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β -cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. Journal of Cellular Physiology 2010 224 2 423 432 2-s2.0-77953644361 10.1002/jcp.22138
30. Kim S., Jin Y., Choi Y., Park T., Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochemical Pharmacology 2011 81 11 1343 1351 2-s2.0-79955611314 10.1016/j.bcp.2011.03.012
31. Chen L. L., Zhang H. H., Zheng J., Hu X., Kong W., Hu D., Wang S. X., Zhang P., Resveratrol attenuates high-fat diet-induced insulin resistance by influencing skeletal muscle lipid transport and subsarcolemmal mitochondrial beta-oxidation. Metabolism 2011 60 1598 1609
32. Saraceni C., Broderick T. L., Cardiac and metabolic consequences of aerobic exercise training in experimental diabetes. Current Diabetes Reviews 2007 3 1 75 84 2-s2.0-34247130840 10.2174/157339907779802111 (Pubitemid 46592796)
33. Bradley R. L., Jeon J. Y., Liu F. F., Maratos-Flier E., Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. American Journal of Physiology 2008 295 3 E586 E594 2-s2.0-53149132796 10.1152/ajpendo.00309.2007
34. Mannerås L., Jonsdottir I. H., Holmäng A., Lönn M., Stener-Victorin E., Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology 2008 149 7 3559 3568 2-s2.0-46349104851 10.1210/en.2008-0053 (Pubitemid 351919588)
35. Yoshino J., Conte C., Fontana L., Mittendorfer B., Imai S. I., Schechtman K. B., Gu C., Kunz I., Fanelli F. R., Patterson B. W., Klein S., Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metabolism 2012 16 5 658 664 10.1016/j.cmet.2012. 09.015
36. Kang W., Hong H. J., Guan J., Kim D. G., Yang E. J., Koh G., Park D., Han C. H., Lee Y. J., Lee D. H., Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. Metabolism 2012 61 424 433
37. Harrison C. L., Lombard C. B., Moran L. J., Teede H. J., Exercise therapy in polycystic ovary syndrome: a systematic review. Human Reproduction Update 2011 17 2 171 183 2-s2.0-79951755056 10.1093/humupd/dmq045
38. You T., Murphy K. M., Lyles M. F., Demons J. L., Lenchik L., Nicklas B. J., Addition of aerobic exercise to dietary weight loss preferentially reduces abdominal adipocyte size. International Journal of Obesity 2006 30 8 1211 1216 2-s2.0-33746493309 10.1038/sj.ijo.0803245 (Pubitemid 44141609)
39. Alberdi G., Rodriguez V. M., Miranda J., Macarulla M. T., Arias N., Andres-Lacueva C., Portillo M. P., Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutrition & Metabolism 2011 8 29
40. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha α Cell 2006 127 6 1109 1122 2-s2.0-33845399894 10.1016/j.cell.2006.11.013 (Pubitemid 44894520)
41. Lasa A., Schweiger M., Kotzbeck P., Churruca I., Simón E., Zechner R., del Puy Portillo M., Resveratrol regulates lipolysis via adipose triglyceride lipase. Journal of Nutritional Biochemistry 2012 23 379 384 2-s2.0-79955380600 10.1016/j.jnutbio.2010.12.014
42. Baile C. A., Yang J. Y., Rayalam S., Hartzell D. L., Lai C. Y., Andersen C., Della-Fera M. A., Effect of resveratrol on fat mobilization. Annals of the New York Academy of Sciences 2011 1215 1 40 47 2-s2.0-78851469588 10.1111/j.1749-6632.2010.05845.x
43. Macarulla M. T., Alberdi G., Gómez S., Tueros I., Bald C., Rodríguez V. M., Martínez J. A., Portilio M. P., Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. Journal of Physiology and Biochemistry 2009 65 4 369 376 2-s2.0-77950841396 10.1007/BF03185932
44. Deblois G., Giguère V., Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochimica et Biophysica Acta 2011 1812 8 1032 1040 2-s2.0-79958264634 10.1016/j.bbadis.2010. 12.009
45. Gao M., Wei L. H., Sun P. M., Wang J. L., Zhao D., Zhao C., Wang Z. Q., Regulation of orphan receptor ERR α by estrogen and progesterone in endometrial carcinoma cell line. Journal of Peking University. Health Sciences 2005 37 3 281 283 2-s2.0-39049189909
46. Nilsson M., Ohlsson C., Mellstrom D., Lorentzon M., Sport-specific association between exercise loading and the density, geometry, and microstructure of weight-bearing bone in young adult men. Osteoporosis International 2012 10.1007/s00198-012-2142-3
47. Barengolts E. I., Lathon P. V., Curry D. J., Kukreja S. C., Effects of endurance exercise on bone histomorphometric parameters in intact and ovariectomized rats. Bone and Mineral 1994 26 2 133 140 2-s2.0-0028167776
48. Yingling V. R., Davies S., Silva M. J., The effects of repetitive physiologic loading on bone turnover and mechanical properties in adult female and male rats. Calcified Tissue International 2001 68 4 235 239 2-s2.0-0035031118 10.1007/s00223-001-0007-4 (Pubitemid 32423110)
49. Boissy P., Andersen T. L., Abdallah B. M., Kassem M., Plesner T., Delaissé J. M., Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Research 2005 65 21 9943 9952 2-s2.0-27544495989 10.1158/0008-5472.CAN-05-0651 (Pubitemid 41541475)
50. Rayalam S., Della-Fera M. A., Baile C. A., Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis. Molecular Nutrition and Food Research 2011 55 8 1177 1185 2-s2.0-79960110969 10.1002/mnfr.201000616
51. Su J. L., Yang C. Y., Zhao M., Kuo M. L., Yen M. L., Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. Journal of Biological Chemistry 2007 282 27 19385 19398 2-s2.0-34547107359 10.1074/jbc.M702452200 (Pubitemid 47100112)
52. Liu Z. P., Li W. X., Yu B., Huang J., Sun J., Huo J. S., Liu C. X., Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. Journal of Medicinal Food 2005 8 1 14 19 2-s2.0-18144380684 10.1089/jmf.2005.8.14 (Pubitemid 40617031)
53. Pearson K. J., Baur J. A., Lewis K. N., Peshkin L., Price N. L., Labinskyy N., Swindell W. R., Kamara D., Minor R. K., Perez E., Jamieson H. A., Zhang Y., Dunn S. R., Sharma K., Pleshko N., Woollett L. A., Csiszar A., Ikeno Y., Le Couteur D., Elliott P. J., Becker K. G., Navas P., Ingram D. K., Wolf N. S., Ungvari Z., Sinclair D. A., de Cabo R., Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism 2008 8 2 157 168 2-s2.0-48349144852 10.1016/j.cmet.2008.06.011
54. Stener-Victorin E., Jedel E., Janson P. O., Sverrisdottir Y. B., Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. American Journal of Physiology 2009 297 2 R387 R395 2-s2.0-68049100394 10.1152/ajpregu.00197.2009
55. Duggal P. S., Van Der Hoek K. H., Milner C. R., Ryan N. K., Armstrong D. T., Magoffin D. A., Norman R. J., The in vivo and in vitro effects of exogenous leptin on ovulation in the rat. Endocrinology 2000 141 6 1971 1976 2-s2.0-0034458148 10.1210/en.141.6.1971 (Pubitemid 32274345)
56. Dolinsky V. W., Rueda-Clausen C. F., Morton J. S., Davidge S. T., Dyck J. R., Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes 2011 60 2274 2284
57. Biasutto L., Marotta E., Garbisa S., Zoratti M., Paradisi C., Determination of quercetin and resveratrol in whole blood-implications for bioavailability studies. Molecules 2010 15 9 6570 6579 2-s2.0-77957315722 10.3390/molecules15096570
58. Juan M. E., Maijó M., Planas J. M., Quantification of trans-resveratrol and its metabolites in rat plasma and tissues by HPLC. Journal of Pharmaceutical and Biomedical Analysis 2010 51 2 391 398 2-s2.0-70349843880 10.1016/j.jpba.2009.03.026